Stocks With The Highest
Upside Forecast

Based on 25,000+ 1-year price targets provided by
5,000+ Wall Street analysts over the past 3-months

#	Name	Upside %	Analysts bullish %
76	76 Soleno Therapeutics SLNO $3.01B	101% upside 5 price targets	0
77	77 NovoCure NVCR $1.45B	101% upside 3 price targets	0
78	78 Viant Technology DSP $153M	100% upside 5 price targets	0
79	79 Microvision MVIS $376M	100% upside 3 price targets	0
80	80 Nuvation Bio NUVB $1.09B	100% upside 3 price targets	0
81	81 BioCryst Pharmaceuticals BCRX $1.67B	98% upside 4 price targets	0
82	CBIO 82 Crescent Biopharma, Inc. Common Stock CBIO $180M	98% upside 5 price targets	0
83	83 MannKind Corp MNKD $1.72B	96% upside 4 price targets	0
84	84 Immunovant IMVT $2.68B	95% upside 4 price targets	0
85	85 Arvinas ARVN $567M	92% upside 6 price targets	0
86	86 Criteo CRTO $1.15B	92% upside 5 price targets	0
87	87 Evolent Health EVH $1.01B	90% upside 5 price targets	0
88	88 Arrowhead Research ARWR $4.36B	88% upside 3 price targets	0
89	89 KALA BIO KALA $123M	86% upside 3 price targets	0
90	90 KalVista Pharmaceuticals KALV $701M	86% upside 4 price targets	0
91	IMAB 91 I-MAB IMAB $298M	85% upside 4 price targets	0
92	92 Celldex Therapeutics CLDX $1.72B	83% upside 4 price targets	0
93	93 DiaMedica Therapeutics DMAC $349M	82% upside 3 price targets	0
94	94 IDEAYA Biosciences IDYA $2.3B	81% upside 8 price targets	0
95	95 Strategy Inc Common Stock Class A MSTR $99B	80% upside 6 price targets	0
96	96 UroGen Pharma URGN $873M	78% upside 3 price targets	0
97	97 Generation Bio GBIO $40.3M	78% upside 3 price targets	0
98	MTSR 98 Metsera, Inc. Common Stock MTSR $3.77B	78% upside 3 price targets	0
99	99 Innoviva INVA $1.25B	78% upside 3 price targets	0
100	100 BioMarin Pharmaceuticals BMRN $10.6B	77% upside 5 price targets	0